Home
OLMA
OLMA News

Latest Olema Pharmaceuticals Inc. (OLMA) News on May 10, 2025

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

7 days ago

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

MT Newswires

11 days ago

Top Premarket Decliners

MT Newswires

14 days ago

Olema Pharmaceuticals Says OP-3136 Molecule Shows Anti-Tumor Activity in Preclinical Models

Olema Oncology Announces New Preclinical Data for OP-3136 Demonstrating Anti-Tumor Activity in Multiple Solid Tumor Models at AACR 2025

GlobeNewswire

14 days ago

Olema Oncology Announces New Preclinical Data for OP-3136 Demonstrating Anti-Tumor Activity in Multiple Solid Tumor Models at AACR 2025

Wall Street Analysts Think Olema Pharmaceuticals (OLMA) Could Surge 433.13%: Read This Before Placing a Bet

Zacks

16 days ago

Wall Street Analysts Think Olema Pharmaceuticals (OLMA) Could Surge 433.13%: Read This Before Placing a Bet

After Plunging -30.16% in 4 Weeks, Here's Why the Trend Might Reverse for Olema Pharmaceuticals (OLMA)

Zacks

a month ago

After Plunging -30.16% in 4 Weeks, Here's Why the Trend Might Reverse for Olema Pharmaceuticals (OLMA)

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

a month ago

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

MT Newswires

a month ago

Top Premarket Decliners

Olema Oncology to Present Preclinical Data for OP-3136, a Potent KAT6 Inhibitor, Demonstrating Anti-Tumor Activity in Multiple Solid Tumor Models at the 2025 AACR Annual Meeting

GlobeNewswire

a month ago

Olema Oncology to Present Preclinical Data for OP-3136, a Potent KAT6 Inhibitor, Demonstrating Anti-Tumor Activity in Multiple Solid Tumor Models at the 2025 AACR Annual Meeting

MT Newswires

2 months ago

Olema Pharmaceuticals Q4 Net Loss Widens

Olema Oncology Reports Fourth Quarter and Full Year 2024 Financial and Operating Results

GlobeNewswire

2 months ago

Olema Oncology Reports Fourth Quarter and Full Year 2024 Financial and Operating Results

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

2 months ago

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Olema Oncology to Present at the TD Cowen 45th Annual Health Care Conference

GlobeNewswire

3 months ago

Olema Oncology to Present at the TD Cowen 45th Annual Health Care Conference

Olema Oncology Appoints Shawnte M. Mitchell, J.D. as Chief Legal Officer and Corporate Secretary

GlobeNewswire

3 months ago

Olema Oncology Appoints Shawnte M. Mitchell, J.D. as Chief Legal Officer and Corporate Secretary

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

3 months ago

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Olema Oncology to Participate in Upcoming Investor Conferences

GlobeNewswire

3 months ago

Olema Oncology to Participate in Upcoming Investor Conferences

MT Newswires

4 months ago

Top Midday Decliners

MT Newswires

4 months ago

Olema Pharmaceuticals Files Shelf for 2 Equity Offerings

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

4 months ago

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Olema Oncology to Present at 43rd Annual J.P. Morgan Healthcare Conference

GlobeNewswire

4 months ago

Olema Oncology to Present at 43rd Annual J.P. Morgan Healthcare Conference

Olema Oncology Presents Updated Clinical Results for Palazestrant in Combination with Ribociclib at the San Antonio Breast Cancer Symposium

GlobeNewswire

5 months ago

Olema Oncology Presents Updated Clinical Results for Palazestrant in Combination with Ribociclib at the San Antonio Breast Cancer Symposium

MT Newswires

5 months ago

Olema Pharmaceuticals Cleared to Begin Testing Prospective Breast Cancer Candidate

Olema Oncology Announces FDA Clearance of Investigational New Drug Application for OP-3136, a Potent KAT6 Inhibitor

GlobeNewswire

5 months ago

Olema Oncology Announces FDA Clearance of Investigational New Drug Application for OP-3136, a Potent KAT6 Inhibitor

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

5 months ago

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Novartis In-Licenses PTCT's Huntington's Disease Drug for $2.9 Billion

Zacks

5 months ago

Novartis In-Licenses PTCT's Huntington's Disease Drug for $2.9 Billion

Novartis and Olema expand alliance with $250m to boost breast cancer trials

Pharmaceutical Technology

5 months ago

Novartis and Olema expand alliance with $250m to boost breast cancer trials

MT Newswires

5 months ago

Olema Partners With Novartis for Clinical Trial of Potential Breast Cancer Drug, Launches $250 Million Stock, Warrant Placement

Olema Oncology Announces New Clinical Trial Collaboration and Supply Agreement with Novartis in Frontline Metastatic Breast Cancer as well as $250 Million Equity Private Placement

GlobeNewswire

5 months ago

Olema Oncology Announces New Clinical Trial Collaboration and Supply Agreement with Novartis in Frontline Metastatic Breast Cancer as well as $250 Million Equity Private Placement

Olema Oncology to Present New Data Combining Palazestrant with Ribociclib at the San Antonio Breast Cancer Symposium

GlobeNewswire

5 months ago

Olema Oncology to Present New Data Combining Palazestrant with Ribociclib at the San Antonio Breast Cancer Symposium

Ascentage Pharma Appoints Ms. Marina S. Bozilenko and Dr. Debra Yu as Independent Non-Executive Directors

PR Newswire

6 months ago

Ascentage Pharma Appoints Ms. Marina S. Bozilenko and Dr. Debra Yu as Independent Non-Executive Directors

Olema Oncology Reports Third Quarter 2024 Financial Results and Provides Corporate Update

GlobeNewswire

6 months ago

Olema Oncology Reports Third Quarter 2024 Financial Results and Provides Corporate Update

Olema Oncology to Participate in Upcoming Investor Conferences

GlobeNewswire

6 months ago

Olema Oncology to Participate in Upcoming Investor Conferences

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

6 months ago

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Here's Why We're Not Too Worried About Olema Pharmaceuticals' (NASDAQ:OLMA) Cash Burn Situation

Simply Wall St.

6 months ago

Here's Why We're Not Too Worried About Olema Pharmaceuticals' (NASDAQ:OLMA) Cash Burn Situation

Olema Oncology Presents Compelling New Preclinical Data Demonstrating Anti-Tumor Activity for OP-3136 with Enhanced Activity of Palazestrant Combinations at ENA 2024

GlobeNewswire

7 months ago

Olema Oncology Presents Compelling New Preclinical Data Demonstrating Anti-Tumor Activity for OP-3136 with Enhanced Activity of Palazestrant Combinations at ENA 2024

Olema Oncology Announces New Preclinical Combination Data to be Presented at the 2024 EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics

GlobeNewswire

7 months ago

Olema Oncology Announces New Preclinical Combination Data to be Presented at the 2024 EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

7 months ago

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

8 months ago

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Olema Oncology to Participate in Morgan Stanley 22nd Annual Global Healthcare Conference

GlobeNewswire

9 months ago

Olema Oncology to Participate in Morgan Stanley 22nd Annual Global Healthcare Conference

Olema Oncology Reports Second Quarter 2024 Financial Results and Provides Corporate Update

GlobeNewswire

9 months ago

Olema Oncology Reports Second Quarter 2024 Financial Results and Provides Corporate Update

Recent Price Trend in Olema Pharmaceuticals (OLMA) is Your Friend, Here's Why

Zacks

9 months ago

Recent Price Trend in Olema Pharmaceuticals (OLMA) is Your Friend, Here's Why

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

10 months ago

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

TruBridge, Evans Bancorp, and More Stocks See Action From Activist Investors

Barrons.com

a year ago

TruBridge, Evans Bancorp, and More Stocks See Action From Activist Investors

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

a year ago

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Olema Oncology to Participate in Upcoming Investor Conferences in June

GlobeNewswire

a year ago

Olema Oncology to Participate in Upcoming Investor Conferences in June

Olema Pharmaceuticals (NASDAQ:OLMA) Is In A Good Position To Deliver On Growth Plans

Simply Wall St.

a year ago

Olema Pharmaceuticals (NASDAQ:OLMA) Is In A Good Position To Deliver On Growth Plans

Olema Oncology Announces Promising New Data for Palazestrant in Combination with Ribociclib Presented at the 2024 ESMO Breast Cancer Congress

GlobeNewswire

a year ago

Olema Oncology Announces Promising New Data for Palazestrant in Combination with Ribociclib Presented at the 2024 ESMO Breast Cancer Congress

Olema Oncology Reports First Quarter 2024 Financial Results and Provides Corporate Update

GlobeNewswire

a year ago

Olema Oncology Reports First Quarter 2024 Financial Results and Provides Corporate Update

Olema Oncology Announces New Clinical Data for Palazestrant in Combination with Ribociclib to be Presented at the 2024 ESMO Breast Cancer Annual Congress

GlobeNewswire

a year ago

Olema Oncology Announces New Clinical Data for Palazestrant in Combination with Ribociclib to be Presented at the 2024 ESMO Breast Cancer Annual Congress

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

a year ago

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Olema Oncology to Participate in Upcoming Investor Conferences in May

GlobeNewswire

a year ago

Olema Oncology to Participate in Upcoming Investor Conferences in May

Olema Oncology to Participate in Canaccord Genuity 2024 Horizons in Oncology Virtual Conference

GlobeNewswire

a year ago

Olema Oncology to Participate in Canaccord Genuity 2024 Horizons in Oncology Virtual Conference

Goldman Sachs Predicts Over 120% Rally for These 2 ‘Strong Buy’ Stocks

TipRanks

a year ago

Goldman Sachs Predicts Over 120% Rally for These 2 ‘Strong Buy’ Stocks

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

a year ago

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Olema Oncology Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Corporate Update

GlobeNewswire

a year ago

Olema Oncology Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Corporate Update

Olema Oncology Announces Publication of Data Highlighting Palazestrant’s Ability to Inhibit Wild-Type and Mutant ER+ Breast Cancer Both as Monotherapy and in Combination with CDK4/6 Inhibitors

GlobeNewswire

a year ago

Olema Oncology Announces Publication of Data Highlighting Palazestrant’s Ability to Inhibit Wild-Type and Mutant ER+ Breast Cancer Both as Monotherapy and in Combination with CDK4/6 Inhibitors

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

a year ago

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Calculating The Intrinsic Value Of Olema Pharmaceuticals, Inc. (NASDAQ:OLMA)

Simply Wall St.

a year ago

Calculating The Intrinsic Value Of Olema Pharmaceuticals, Inc. (NASDAQ:OLMA)

Olema Oncology to Participate in Upcoming Investor Conferences

GlobeNewswire

a year ago

Olema Oncology to Participate in Upcoming Investor Conferences

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

a year ago

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Associated Press Finance

a year ago

Deluxe: Q4 Earnings Snapshot

The First Bancshares, Inc. (NASDAQ:FBMS) Q4 2023 Earnings Call Transcript

Insider Monkey

a year ago

The First Bancshares, Inc. (NASDAQ:FBMS) Q4 2023 Earnings Call Transcript

Teekay Corporation (NYSE:TK) is a favorite amongst institutional investors who own 86%

Simply Wall St.

a year ago

Teekay Corporation (NYSE:TK) is a favorite amongst institutional investors who own 86%

Isabeau Levito edges Amber Glenn in figure skating nationals short program

NBC Sports

a year ago

Isabeau Levito edges Amber Glenn in figure skating nationals short program

Tuya Smart Delivers IoT Best Practice Using Amazon Aurora, Leads the Direction of Cloud Database Innovation Use Cases with Amazon Web Services

PR Newswire

a year ago

Tuya Smart Delivers IoT Best Practice Using Amazon Aurora, Leads the Direction of Cloud Database Innovation Use Cases with Amazon Web Services

Autolus Therapeutics announces publication in ACS Chemical Biology

GlobeNewswire

a year ago

Autolus Therapeutics announces publication in ACS Chemical Biology

15 Small-Cap Stocks with High Potential

Insider Monkey

a year ago

15 Small-Cap Stocks with High Potential

Unpacking Q3 Earnings: BJ's (NASDAQ:BJRI) In The Context Of Other Sit-Down Dining Stocks

StockStory

a year ago

Unpacking Q3 Earnings: BJ's (NASDAQ:BJRI) In The Context Of Other Sit-Down Dining Stocks

Global Blue Announces Date for Q3 and 9M FY 2023/24 Financial Results

Business Wire

a year ago

Global Blue Announces Date for Q3 and 9M FY 2023/24 Financial Results

Sit-Down Dining Stocks Q3 In Review: Texas Roadhouse (NASDAQ:TXRH) Vs Peers

StockStory

a year ago

Sit-Down Dining Stocks Q3 In Review: Texas Roadhouse (NASDAQ:TXRH) Vs Peers

Specialty Retail Stocks Q3 Recap: Benchmarking Tractor Supply (NASDAQ:TSCO)

StockStory

a year ago

Specialty Retail Stocks Q3 Recap: Benchmarking Tractor Supply (NASDAQ:TSCO)

Associated Press Finance

a year ago

OceanFirst: Q4 Earnings Snapshot

OceanFirst Financial Corp. Announces Quarterly and Annual Earnings and Financial Results

GlobeNewswire

a year ago

OceanFirst Financial Corp. Announces Quarterly and Annual Earnings and Financial Results

Leslie’s, Inc. to Report First Quarter Fiscal 2024 Financial Results on February 1, 2024

GlobeNewswire

a year ago

Leslie’s, Inc. to Report First Quarter Fiscal 2024 Financial Results on February 1, 2024

3 Stocks to Buy for Growth and Stability

Zacks

a year ago

3 Stocks to Buy for Growth and Stability

We Ran A Stock Scan For Earnings Growth And Orion (NYSE:OEC) Passed With Ease

Simply Wall St.

a year ago

We Ran A Stock Scan For Earnings Growth And Orion (NYSE:OEC) Passed With Ease

Cohen & Steers Announces Retirement of William Scapell, Head of Fixed Income and Preferred Securities, Effective August 1, 2024

PR Newswire

a year ago

Cohen & Steers Announces Retirement of William Scapell, Head of Fixed Income and Preferred Securities, Effective August 1, 2024

First Majestic (AG) 2023 Silver-Equivalent Production Falls Y/Y

Zacks

a year ago

First Majestic (AG) 2023 Silver-Equivalent Production Falls Y/Y

Q3 Rundown: Darden (NYSE:DRI) Vs Other Sit-Down Dining Stocks

StockStory

a year ago

Q3 Rundown: Darden (NYSE:DRI) Vs Other Sit-Down Dining Stocks

Glo Fiber Launches Lightning Fast Fiber Optic Internet in Rockingham County, VA

PR Newswire

a year ago

Glo Fiber Launches Lightning Fast Fiber Optic Internet in Rockingham County, VA

Orion S.A. Announces Full Year 2023 Earnings Release Date and Conference Call Information

Business Wire

a year ago

Orion S.A. Announces Full Year 2023 Earnings Release Date and Conference Call Information

Grid Dynamics Earns the AI and Machine Learning on Microsoft Azure Advanced Specialization

ACCESSWIRE

a year ago

Grid Dynamics Earns the AI and Machine Learning on Microsoft Azure Advanced Specialization

Investors in Kiniksa Pharmaceuticals (NASDAQ:KNSA) have seen returns of 30% over the past year

Simply Wall St.

a year ago

Investors in Kiniksa Pharmaceuticals (NASDAQ:KNSA) have seen returns of 30% over the past year

13 High-Growth Canadian Dividend Stocks To Invest In

Insider Monkey

a year ago

13 High-Growth Canadian Dividend Stocks To Invest In

Huron Consulting Group Inc CEO C. Hussey Sells 4,000 Shares

GuruFocus.com

a year ago

Huron Consulting Group Inc CEO C. Hussey Sells 4,000 Shares

Optimism for TechTarget (NASDAQ:TTGT) has grown this past week, despite five-year decline in earnings

Simply Wall St.

a year ago

Optimism for TechTarget (NASDAQ:TTGT) has grown this past week, despite five-year decline in earnings

Associated Press Finance

a year ago

TechTarget, Chesapeake Energy rise; Hertz Global, KB Home fall, Thursday, 1/11/2024

Reuters

a year ago

TechTarget to combine with UK-based Informa's digital businesses

TechTarget to Expand Scale and Leadership Position in B2B Data and Market Access through Strategic Combination with Informa Tech’s Digital Businesses

Business Wire

a year ago

TechTarget to Expand Scale and Leadership Position in B2B Data and Market Access through Strategic Combination with Informa Tech’s Digital Businesses

Wolverine (WWW) Announces Its Preliminary Results for 2023

Zacks

a year ago

Wolverine (WWW) Announces Its Preliminary Results for 2023

Vericel Announces Preliminary Full-Year and Fourth Quarter 2023 Financial Results

GlobeNewswire

a year ago

Vericel Announces Preliminary Full-Year and Fourth Quarter 2023 Financial Results

Business Wire

a year ago

CBRE Global Real Estate Income Fund (NYSE: IGR) Declares Monthly Distribution for January, February and March and Announces a Webinar with Portfolio Management

Under Armour (UAA) Gains on Strategic Innovations, Expansions

Zacks

a year ago

Under Armour (UAA) Gains on Strategic Innovations, Expansions

Olema Oncology Nominates OP-3136, an Orally Bioavailable KAT6 Inhibitor, as a Development Candidate

GlobeNewswire

a year ago

Olema Oncology Nominates OP-3136, an Orally Bioavailable KAT6 Inhibitor, as a Development Candidate

Why it is Worth Betting on Principal Financial (PFG) Stock

Zacks

a year ago

Why it is Worth Betting on Principal Financial (PFG) Stock

Best Workplace Injury Lawyers in Each of 30 Biggest Cities in the US

Insider Monkey

a year ago

Best Workplace Injury Lawyers in Each of 30 Biggest Cities in the US

Olema Oncology to Present at 42nd Annual J.P. Morgan Healthcare Conference

GlobeNewswire

a year ago

Olema Oncology to Present at 42nd Annual J.P. Morgan Healthcare Conference

Avanos Medical, Inc. to Present at the 42nd Annual J.P. Morgan Healthcare Conference

PR Newswire

a year ago

Avanos Medical, Inc. to Present at the 42nd Annual J.P. Morgan Healthcare Conference

Owning 29% shares,institutional owners seem interested in Paysafe Limited (NYSE:PSFE),

Simply Wall St.

a year ago

Owning 29% shares,institutional owners seem interested in Paysafe Limited (NYSE:PSFE),

Edgewise Therapeutics Inc Director Jonathan Fox Acquires 10,857 Shares

GuruFocus.com

a year ago

Edgewise Therapeutics Inc Director Jonathan Fox Acquires 10,857 Shares

Share on Social Networks: